Oxidative Stress-Induced miR-200c Disrupts the Regulatory Loop among SIRT1, FOXO1, and eNOS

Antioxidants and Redox Signaling

Volumn 27, Issue 6, 2017, Pages 328-344

  Carlomosti, Fabrizio ^a   D'Agostino, Marco ^b   Beji, Sara ^a   Torcinaro, Alessio ^c,d   Rizzi, Roberto ^d   Zaccagnini, Germana ^e   Maimone, Biagina ^e   Di Stefano, Valeria ^a   De Santa, Francesca ^d,f   Cordisco, Sonia ^a   Antonini, Annalisa ^a   Ciarapica, Roberta ^a   Dellambra, Elena ^a   Martelli, Fabio ^e   Avitabile, Daniele ^g   Capogrossi, Maurizio Colognesi ^a   Magenta, Alessandra ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CNR   (Italy)

^e IRCCS POLICLINICO SAN DONATO   (Italy)

^f IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^g CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

aging; Free radicals; microRNA; nitric oxide; vascular

Indexed keywords

CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA 200C; SIRTUIN 1; TRANSCRIPTION FACTOR FKHR; FOXO1 PROTEIN, HUMAN; MICRORNA; MIRN200 MICRORNA, HUMAN; NITRIC OXIDE; NOS3 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; SHC TRANSFORMING PROTEIN 1; SHC1 PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; FEMORAL ARTERY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; LIMB PERFUSION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; UPREGULATION; ACETYLATION; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; FIBROBLAST; GENETICS; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ACETYLATION; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROBLASTS; FORKHEAD BOX PROTEIN O1; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICRORNAS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIRTUIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1;

EID: 85025822766     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2016.6643     Document Type: Article

References (49)

1. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376, 2003.
2. Alp NJ and Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arter Thromb Vasc Biol 24: 413-420, 2004.
3. Avitabile D, Magenta A, Lauri A, Gambini E, Spaltro G, and Vinci MC. Metaboloepigenetics: the emerging network in stem cell homeostasis regulation. Curr Stem Cell Res Ther 11: 352-369, 2016.
4. Avitabile D, Ranieri D, Nicolussi A, D'Inzeo S, Capriotti AL, Genovese L, et al. Peroxiredoxin 2 nuclear levels are regulated by circadian clock synchronization in human keratinocytes. Int J Biochem Cell Biol 53: 24-34, 2014.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
6. Chen Z, Shentu TP, Wen L, Johnson DA, and Shyy JY. Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium. Antioxid Redox Signal 19: 1522-1538, 2013.
7. Choi Y-C, Yoon S, Jeong Y, Yoon J, and Baek K. Regulation of vascular endothelial growth factor signaling by miR-200b. Mol Cells 32: 77-82, 2011.
8. Cooper ME and El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circ Res 107: 1403-1413, 2010.
9. Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA, et al. Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther 22: 1494-1503, 2014.
10. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, and Isner JM. Mouse model of angiogenesis. Am J Pathol 152: 1667-1679, 1998.
11. Cui H, Kong Y, and Zhang H. Oxidative stress, mitochondrial dysfunction, and aging. J Signal Transduct 2012: 646354, 2012.
12. Dansen TB. Forkhead boxO transcription factors: key players in redox signaling. Antioxid Redox Signal 14: 559-561, 2011.
13. Deanfield JE, Halcox JP, and Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115: 1285-1295, 2007.
14. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, and Zhou Q. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem 286: 25992-26002, 2011.
15. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883, 2008.
16. Follenzi A and Naldini L. HIV-based vectors. Preparation and use. Methods Mol Med 69: 259-274, 2002.
17. Frischer H and Ahmad T. Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU [1, 3-bis(chloroethyl)-1-nitrosourea]. J Lab Clin Med 89: 1080-1091, 1977.
18. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233, 2005.
19. Giorgio M, Trinei M, Migliaccio E, and Pelicci PG. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 8: 722-728, 2007.
20. Giustarini D, Dalle-Donne I, Tsikas D, and Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 46: 241-281, 2009.
21. Hashimoto A, Miyakoda G, Hirose Y, and Mori T. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/ protein kinase A-and phosphatidylinositol 3-kinase/Aktdependent mechanism. Atherosclerosis 189: 350-357, 2006.
22. Kang DH, Lee DJ, Lee KW, Park YS, Lee JY, Lee S-H, et al. Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol Cell 44: 545-558, 2011.
23. Khanday FA, Yamamori T, Mattagajasingh I, Zhang Z, Bugayenko A, Naqvi A, et al. Rac1 leads to phosphorylationdependent increase in stability of the p66shc adaptor protein: role in Rac1-induced oxidative stress. Mol Biol Cell 17: 122-129, 2006.
24. Lee KW, Lee DJ, Lee JY, Kang DH, Kwon J, and Kang SW. Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair. J Biol Chem 286: 8394-8404, 2011.
25. Li H and Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 190: 244-254, 2000.
26. Li H and Forstermann U. Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des 15: 3133-3145, 2009.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25: 402-408, 2003.
28. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G, et al. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 18: 1628-1639, 2011.
29. Magenta A, Greco S, Capogrossi MC, Gaetano C, and Martelli F. Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction. Biomed Res Int 2014: 193095, 2014.
30. Magenta A, Greco S, Gaetano C, and Martelli F. Oxidative stress and microRNAs in vascular diseases. Int J Mol Sci 14: 17319-17346, 2013.
31. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 17: 1627-1635, 2011.
32. Munoz-Espin D and Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol 15: 482-496, 2014.
33. Napoli C and Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32: 1103-1108, 2009.
34. Nemoto S and Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450-2452, 2002.
35. Nims RW, Cook JC, Krishna MC, Christodoulou D, Poore CM, Miles AM, et al. Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 268: 93-105, 1996.
36. Paniagua OA, Bryant MB, and Panza JA. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation 103: 1752-1758, 2001.
37. Peskin AV, Low FM, Paton LN, Maghzal GJ, Hampton MB, and Winterbourn CC. The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents. J Biol Chem 282: 11885-11892, 2007.
38. Potente M and Dimmeler S. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7: 2117-2122, 2008.
39. Ranieri D, Avitabile D, Shiota M, Yokomizo A, Naito S, Bizzarri M, et al. Nuclear redox imbalance affects circadian oscillation in HaCaT keratinocytes. Int J Biochem Cell Biol 65: 113-124, 2015.
40. Ray PD, Huang BW, and Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24: 981-990, 2012.
41. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831-2841, 1998.
42. Shi L, Zhang S, Wu H, Zhang L, Dai X, Hu J, et al. MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway. PLoS One 8: e78344, 2013.
43. Shiota M, Yokomizo A, Kashiwagi E, Takeuchi A, Fujimoto N, Uchiumi T, et al. Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells. Free Radic Biol Med 51: 78-87, 2011.
44. Sobotta MC, Liou W, Stöcker S, Talwar D, Oehler M, Ruppert T, et al. Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. Nat Chem Biol 11: 64-70, 2015.
45. Xia N, Strand S, Schlufter F, Siuda D, Reifenberg G, Kleinert H, et al. Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol. Nitric Oxide 32: 29-35, 2013.
46. Yamaguchi H, Woods NT, Piluso LG, Lee H-H, Chen J, Bhalla KN, et al. p53 acetylation is crucial for its transcription-independent proapoptotic functions. J Biol Chem 284: 11171-11183, 2009.
47. Yang YM, Huang A, Kaley G, and Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Hear Circ Physiol 297: H1829-H1836, 2009.
48. Zaccagnini G, Martelli F, Fasanaro P, Magenta A, Gaetano C, Di Carlo A, et al. p66ShcA modulates tissue response to hindlimb ischemia. Circulation 109: 2917-2923, 2004.
49. Zhang H, Liu J, Qu D, Wang L, Luo J-Y, Lau CW, et al. Inhibition of miR-200c restores endothelial function in diabetic mice through suppression of COX-2. Diabetes 65: 1196-1207, 2016.